North America Vascular Stents Market Overview, Industry Growth Rate, Research Report 2024-2032
North America Vascular Stents Market Overview
Base Year: 2023
Historical Years: 2018-2023
Forecast Years: 2024-2032
Market Growth Rate: 4.9% (2024-2032)
Market Size in 2023: USD 3.7 Billion
Market Forecast in 2032: USD 5.8 Billion
According to the latest North America vascular stents market report by IMARC Group, the market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032. The market is experiencing robust growth, driven primarily by the increasing prevalence of cardiovascular diseases (CVDs) and the rising aging population.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/north-america-vascular-stents-market/requestsample
North America Vascular Stents Industry Trends and Drivers:
Rising Cardiovascular Disease (CVD) Cases:
- Cardiovascular diseases, including coronary artery disease, peripheral artery disease, and other vascular conditions, are leading causes of mortality and morbidity in North America.
- Sedentary lifestyles, unhealthy diets, high smoking prevalence, and increasing rates of obesity and diabetes significantly contribute to the rising incidence of these conditions.
- As the population ages, susceptibility to CVD increases, leading to a higher demand for vascular stents to treat blocked or narrowed blood vessels.
Importance of Stents in Cardiovascular Treatments:
- Stents are crucial in procedures like angioplasty, which helps restore normal blood flow and prevent heart attacks or strokes.
- The escalating number of CVD cases and the expanding geriatric demographic significantly propel the demand for vascular stents in the region.
Advancements in Stent Technology:
- Continuous advancements in stent technology and the increasing adoption of minimally invasive surgical procedures are crucial market drivers.
- Technological innovations have led to the development of drug-eluting stents (DES), bioresorbable stents, and newer generations of bare-metal stents, offering improved safety, efficacy, and patient outcomes.
- Drug-eluting stents, for instance, release medication that prevents restenosis (re-narrowing of the artery), reducing the need for repeat procedures.
Increasing Preference for Minimally Invasive Techniques:
- There is a growing preference for minimally invasive techniques over traditional open-heart surgeries.
- These procedures typically involve shorter hospital stays, faster recovery times, and lower risks of complications, driving market growth.
Enhanced Diagnostic and Imaging Tools:
- The availability of advanced imaging technologies and improved diagnostic tools facilitates the early detection and treatment of vascular diseases, boosting the adoption of stent procedures.
Supportive Regulatory Environment:
- The U.S. Food and Drug Administration (FDA) and Health Canada have streamlined approval processes for new and innovative stent products.
- This regulatory support encourages manufacturers to invest in research and development, accelerating the introduction of advanced stent technologies to the market.
Favorable Reimbursement Policies:
- Comprehensive health insurance coverage and favorable reimbursement policies for cardiovascular procedures, including stent placements, make these treatments more accessible and affordable for a larger patient population.
- This accessibility reduces the financial burden on patients and promotes better healthcare outcomes, further driving the adoption of vascular stents.
North America Vascular Stents Industry Segmentation:
The report has segmented the market into the following categories:
Market by Product Type
- Coronary Stents
- Peripheral Vascular Stents
- EVAR Stent Grafts
Market by Material
- Metallic Stents
- Cobalt Chromium
- Platinum Chromium
- Nickel Titanium
- Stainless Steel
- Others
Market by Mode of Delivery
- Balloon-Expandable Stents
- Self-Expanding Stents
Market by End-User
- Hospitals and Cardiac Centers
- Ambulatory Surgical Centers
Key Regions Analysed
- United States
- Canada
- Mexico
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Ask Our Expert & Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=1695&flag=C
Key highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Comments
Post a Comment